Immuno-inflammatory and organ dysfunction markers in severe COVID-19 patients

被引:1
作者
Ahmed, Najat Jabbar [1 ]
Amin, Zahra A. [2 ]
Kheder, Ramiar Kamal [3 ,4 ]
Pirot, Rzgar Qadir [5 ]
Mutalib, Gulstan A. [1 ]
Jabbar, Sana Najat [1 ]
机构
[1] Erbil Polytech Univ, Erbil Tech Hlth & Med Coll, Dept Med Lab Technol, Erbil 44001, Iraq
[2] Hawler Med Univ, Coll Pharm, Dept Clin Anal, Erbil 44001, Iraq
[3] Univ Raparin, Coll Sci, Med Lab Sci Dept, Rania 46012, Sulaymaniyah, Iraq
[4] Tishk Int Univ, Fac Appl Sci, Dept Med Anal, Erbil, Iraq
[5] Univ Raparin, Coll Sci, Biol Dept, Rania 46012, Sulaymaniyah, Iraq
关键词
SARS CoV-2; Cytokine; Inflammation; Biomarkers; Body organs; COUNT;
D O I
10.1016/j.cyto.2024.156715
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Infection with the SARS-CoV-2 virus may induce some complications among people who experience mild to moderate respiratory illness and some of them recover without requiring special treatment. Albeit, some individuals become seriously reached risk points and require special medical attention especially older people and people who suffer from chronic diseases. Serum and whole blood samples were collected from confirmed infected persons with SARS CoV-2 by real-time PCR and the control group. All lab. Investigations were performed using Cobas 6000. Significant differences were noted between patients compared to the control group in the Mean f SD of IL-6 (76.06 f 7.60 vs 3.61 f 0.296 pg/ml), Procalcitonin (0.947 f 0.117 vs 0.061 f 0.007 ng/ml), CRP (125.3 f 7.560 vs 4.027 f 0.251 mg/dl), ALT (154.8 f 30.47 vs 49.75 f 2.977 IU/L) and AST (70.83 f 9.215 vs 27.23 f 1.767) respectively. While other parameters were also showed significant differences were noted between patients compared to the control group for D-Dimmer, PT, PTT, LDH, Ferritin, WBC, Lymphocyte and Creatinine. The results reached that the effect of SARS CoV-2 and cytokine storm was clear on the body's organs through vital biomarker investigations that were performed in this study.
引用
收藏
页数:7
相关论文
共 49 条
  • [1] Thrombosis in Coronavirus disease 2019 (COVID-19) through the prism of Virchow's triad
    Ahmed, Sakir
    Zimba, Olena
    Gasparyan, Armen Yuri
    [J]. CLINICAL RHEUMATOLOGY, 2020, 39 (09) : 2529 - 2543
  • [2] Serum troponin, D-dimer, and CRP level in severe coronavirus (COVID-19) patients
    Ali, Ayad M.
    Rostam, Hassan M.
    Fatah, Mohammed H.
    Noori, Chalak M.
    Ali, Kameran M.
    Tawfeeq, Hassan M.
    [J]. IMMUNITY INFLAMMATION AND DISEASE, 2022, 10 (03)
  • [3] Baseline procalcitonin as a predictor of bacterial infection and clinical outcomes in COVID-19: A case-control study
    Atallah, Natalie J.
    Warren, Hailey M.
    Roberts, Matthew B.
    Elshaboury, Ramy H.
    Bidell, Monique R.
    Gandhi, Ronak G.
    Adamsick, Meagan
    Ibrahim, Maryam K.
    Sood, Rupali
    Eddine, Savo Bou Zein
    Cobler-Lichter, Matthew J.
    Alexander, Natalie J.
    Timmer, Kyle D.
    Atallah, Christine J.
    Viens, Adam L.
    Panossian, Vahe S.
    Scherer, Allison K.
    Proctor, Teddie
    Smartt, Sherrie
    Letourneau, Alyssa R.
    Paras, Molly L.
    Johannes, Sascha
    Wiemer, Jan
    Mansour, Michael K.
    [J]. PLOS ONE, 2022, 17 (01):
  • [4] The Impact of Coronavirus Disease 2019 (COVID-19) on Healthcare-Associated Infections
    Baker, Meghan A.
    Sands, Kenneth E.
    Huang, Susan S.
    Kleinman, Ken
    Septimus, Edward J.
    Varma, Neha
    Blanchard, Jackie
    Poland, Russell E.
    Coady, Micaela H.
    Yokoe, Deborah S.
    Fraker, Sarah
    Froman, Allison
    Moody, Julia
    Goldin, Laurel
    Isaacs, Amanda
    Kleja, Kacie
    Korwek, Kimberly M.
    Stelling, John
    Clark, Adam
    Platt, Richard
    Perlin, Jonathan B.
    [J]. CLINICAL INFECTIOUS DISEASES, 2022, 74 (10) : 1748 - 1754
  • [5] The Impact of Vaccination on Incidence and Outcomes of SARS-CoV-2 Infection in Patients with Kidney Failure in Scotland
    Bell, Samira
    Campbell, Jacqueline
    Lambourg, Emilie
    Watters, Chrissie
    O'Neil, Martin
    Almond, Alison
    Buck, Katharine
    Carr, Edward J.
    Clark, Laura
    Cousland, Zoe
    Findlay, Mark
    Joss, Nicola
    Metcalfe, Wendy
    Petrie, Michaela
    Spalding, Elaine
    Traynor, Jamie P.
    Sanu, Vinod
    Thomson, Peter
    Methven, Shona
    Mark, Patrick B.
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022, 33 (04): : 677 - 686
  • [6] SARS-CoV-2 variants and vulnerability at the global level
    Chavda, Vivek P.
    Patel, Aayushi B.
    Vaghasiya, Darsh D.
    [J]. JOURNAL OF MEDICAL VIROLOGY, 2022, 94 (07) : 2986 - 3005
  • [7] Immune response and cytokine storm in SARS-CoV-2 infection: Risk factors, ways of control and treatment
    Chegni, Hamid
    Babaii, Hadise
    Hassan, Zuhair M.
    Pourshaban, Manoochehr
    [J]. EUROPEAN JOURNAL OF INFLAMMATION, 2022, 20
  • [8] Dawood RM, 2022, AM J MED SCI, V363, P94, DOI 10.1016/j.amjms.2021.11.001
  • [9] Longitudinal relationship of liver injury with inflammation biomarkers in COVID-19 hospitalized patients using a joint modeling approach
    Diaz-Louzao, Carla
    Barrera-Lopez, Lucia
    Lopez-Rodriguez, Maria
    Casar, Clara
    Vazquez-Agra, Nestor
    Pernas-Pardavila, Hadrian
    Marques-Afonso, Ana
    Vidal-Vazquez, Martin
    Montoya, Jonathan G.
    Andrade, Ariadna H.
    Fernandez-Castro, Ivan
    Varela, Pablo
    Gonzalez-Quintela, Arturo
    Otero, Esteban
    Gude, Francisco
    Cadarso-Suarez, Carmen
    Tome, Santiago
    [J]. SCIENTIFIC REPORTS, 2022, 12 (01)
  • [10] Current and novel biomarkers of thrombotic risk in COVID-19: a Consensus Statement from the International COVID-19 Thrombosis Biomarkers Colloquium
    Gorog, Diana A.
    Storey, Robert F.
    Gurbel, Paul A.
    Tantry, Udaya S.
    Berger, Jeffrey S.
    Chan, Mark Y.
    Duerschmied, Daniel
    Smyth, Susan S.
    Parker, William A. E.
    Ajjan, Ramzi A.
    Vilahur, Gemma
    Badimon, Lina
    ten Berg, Jurrien M.
    ten Cate, Hugo
    Peyvandi, Flora
    Wang, Taia T.
    Becker, Richard C.
    [J]. NATURE REVIEWS CARDIOLOGY, 2022, 19 (07) : 475 - 495